Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Roe

Showing results (271-280 of 468) with videos related to

Pageof 47
Sort By:
Circulation. Cardiovascular Quality and Outcomes|August 14, 2014
Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR)Hurst M Hall, James A de Lemos, Jonathan R Enriquez, et al.
American Heart Journal|July 6, 2010
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trialChee Tang Chin, Matthew T Roe, Keith A A Fox, et al.
American Heart Journal|February 16, 2018
Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline programJay S Shavadia, William French, Anne S Hellkamp, et al.
Circulation. Cardiovascular Interventions|April 14, 2017
Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data RegistryJavier A Valle, Lisa A McCoy, Thomas M Maddox, et al.
The American Journal of Cardiology|January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarctionAjay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
JAMA|December 29, 2005
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromesKaren P Alexander, Anita Y Chen, Matthew T Roe, et al.
American Heart Journal|March 27, 2007
Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarctionMatthew T Roe, Abdul R Halabi, Rajendra H Mehta, et al.
European Heart Journal|August 22, 2008
Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromesMatthew T Roe, Fang-Shu Ou, Karen P Alexander, et al.
The American Journal of Cardiology|September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure StatusAndrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.
Journal of the American College of Cardiology|February 21, 2004
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarctionMatthew T Roe, Cynthia L Green, Robert P Giugliano, et al.
Pageof 47

Showing results (271-280 of 468) with videos related to

Sort By:
Pageof 47
Circulation. Cardiovascular Quality and Outcomes|August 14, 2014
Contemporary patterns of discharge aspirin dosing after acute myocardial infarction in the United States: results from the National Cardiovascular Data Registry (NCDR)Hurst M Hall, James A de Lemos, Jonathan R Enriquez, et al.
American Heart Journal|July 6, 2010
Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trialChee Tang Chin, Matthew T Roe, Keith A A Fox, et al.
American Heart Journal|February 16, 2018
Comprehensive electrocardiogram-to-device time for primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: A report from the American Heart Association mission: Lifeline programJay S Shavadia, William French, Anne S Hellkamp, et al.
Circulation. Cardiovascular Interventions|April 14, 2017
Longitudinal Risk of Adverse Events in Patients With Acute Kidney Injury After Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data RegistryJavier A Valle, Lisa A McCoy, Thomas M Maddox, et al.
The American Journal of Cardiology|January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarctionAjay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
JAMA|December 29, 2005
Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromesKaren P Alexander, Anita Y Chen, Matthew T Roe, et al.
American Heart Journal|March 27, 2007
Documented traditional cardiovascular risk factors and mortality in non-ST-segment elevation myocardial infarctionMatthew T Roe, Abdul R Halabi, Rajendra H Mehta, et al.
European Heart Journal|August 22, 2008
Patterns and prognostic implications of low high-density lipoprotein levels in patients with non-ST-segment elevation acute coronary syndromesMatthew T Roe, Fang-Shu Ou, Karen P Alexander, et al.
The American Journal of Cardiology|September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure StatusAndrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.
Journal of the American College of Cardiology|February 21, 2004
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarctionMatthew T Roe, Cynthia L Green, Robert P Giugliano, et al.
Pageof 47